FindTrial
Sign In

Evaluation of the clinical efficacy and mechanism of the Tongyang and Shentong head-fire acupuncture method for the treatment of mild-to-moderate depression

Evaluation of the clinical efficacy and mechanism of the Tongyang and Shentong head-fire acupuncture method for the treatment of mild-to-moderate depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000623
Enrollment
Unknown
Registered
2024-10-29
Start date
2024-11-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder

Interventions

treatment group:fire needle
control group:sham needle

Sponsors

Beijing University of Chinese Medicine Dongzhimen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Be between the ages of 18-65 years old and of either sex; (2) Meet the diagnostic criteria for depression in DSM-5; (3) Patients with mild-to-moderate depression based on a score of 8 = HAMD-17 = 24; (4) Only taking antidepressants of the selective serotonin reuptake inhibitors class and taking them stably for 1 month or more; (5) No aphasia or mental retardation and can communicate normally; (6) Be right-handed; (7) Informed consent and signing the informed consent form voluntarily.

Exclusion criteria

Exclusion criteria: (1) Secondary depression caused by organic diseases medications or psychiatric disorders such as schizophrenia obsessive-compulsive disorder and bipolar disorder; (2) History of suicide attempt within 1 year severe suicidal ideation or high risk of self-injury with a suicide item >2 on the HAMD-17; (3) Diabetes mellitus hemophilia and patients with bleeding disorders and severe skin diseases of the head; (4) People with severe cardiac hepatic and renal insufficiency cardiovascular and cerebrovascular diseases malignant tumors and other serious physical diseases; (5) Those with organic brain lesions or serious trauma to the brain claustrophobia or metal implants in the body; (6) Those who have taken or used antibiotics (or) microecological regulators continuously in the past 1 month. (7) Alcohol or psychoactive substance dependence or abuse; (8) Pregnant or lactating women; (9) Participation in other clinical studies or acupuncture treatment within the last 1 month.

Design outcomes

Primary

MeasureTime frame
HAMD-17;—

Secondary

MeasureTime frame
SAS;SDS;Traditional Chinese Medicine Syndrome Integral Evaluation Scale;GSRS;MoCA;HAMA-14;PSQI;—

Countries

China

Contacts

Public ContactWang Jun

Beijing University of Chinese Medicine Dongzhimen Hospital

wangjunee@yeah.net15811480301

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026